Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influenza Human Challenge Model
NCT05332899Phase 1Recruiting
- Sponsor
- Emory University
- Start
- May 2022
- Primary completion
- Dec 2027
- Modality
- Oncolytic Viruses
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Influenza A H3N2 strain in influenza, sponsored by Emory University. Primary endpoints: Number of Participants with Mild to Moderate Influenza Disease at 8 days, Number of Serious Adverse Events at 12 weeks and 1 more. Started May 2022; status: recruiting.
02
Drugs
Influenza A H3N2 strain
03
Conditions
influenza
Beyond the preview
Go deeper on NCT05332899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05332899.